FletcherGF, LandolfoC, NiebauerJ, OzemekC, ArenaR, LavieCJ. Promoting physical activity and exercise: JACC Health Promotion Series. J Am Coll Cardiol, 2018; 72:1622–1639.
4.
FarrellS, BarlowC, WillisB, et al.Cardiorespiratory fitness, different measures of adiposity, and cardiovascular disease mortality risk in women. J Womens Health, 2020; 29:319–326.
5.
OrtegaFB, SuiX, LavieCJ, BlairSN. Body mass index, the most widely used but also widely criticized index: Would a criterion standard measure of total body fat be a better predictor of cardiovascular disease mortality?. Mayo Clin Proc, 2016; 91:443–455.
6.
OktayAA, LavieCJ, KokkinosPF, PartoP, PandeyA, VenturaHO. The interaction of cardiorespiratory fitness with obesity and the obesity paradox in cardiovascular disease. Prog Cardiovasc Dis, 2017; 60:30–44.
7.
OrtegaFB, RuizJR, LabayenI, LavieCJ, BlairSN. The Fat but Fit paradox: What we know and don't know about it. Br J Sports Med, 2018; 52:151–153.
8.
ImbodenMT, HarberMP, WhaleyMH, et al.The influence of changes in cardiorespiratory fitness with short-term exercise training on mortality risk from the Ball State Adult Fitness Longitudinal Lifestyle Study. Mayo Clin Proc, 2019; 94:1406–1414.
9.
Van PeltRE, GavinKM, KohrtWM. Regulation of body composition and bioenergetics by estrogens. Endocrinol Metab Clin N Am, 2015; 44:663–676.
10.
MoreauKL, OzemekC. Vascular adaptations to habitual exercise in older adults: Time for the sex talk. Exerc Sport Sci Rev, 2017; 45:116–123.
11.
MelansonEL, LydenK, GibbonsE, et al.Influence of estradiol status on physical activity in premenopausal women. Med Sci Sports Exerc, 2018; 50:1704–1709.
12.
BassukSS, MansonJE. The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?. Metabolism, 2016; 65:794–803.
13.
LavieCJ, KokkinosP, OrtegaFB. Survival of the fittest: Promoting fitness throughout the life span. Mayo Clin Proc, 2017; 92:1743–1745.
